Icon

LIVALO (nda022363)- (EQ 1MG BASE,EQ 2MG BASE,EQ 4MG BASE)

PITAVASTATIN CALCIUM KOWA CO
EQ 1MG BASE,EQ 2MG BASE,EQ 4MG BASE
Yes No
2024-Aug-19 2014-Aug-03
None None
None No
LIVALO is a HMG-CoA reductase inhibitor indicated as an adjunctive therapy to diet in: • Adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C). • Pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated TC, LDL-C, and Apo B.
6 1 5
Total Other Developers 1
Drugs with Suitability No
EQ 1MG BASE ** ** Up - 4
EQ 2MG BASE ** ** Up - 4
EQ 4MG BASE ** ** Down - 4
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ** *** ****** ****** **., ***. ****** ***** *********** * **** *** ****, ***** ********, ****** ******, *****, ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ****** **** *** * ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.